Pfizer‘s CAPE ratio
The current Shiller CAPE Ratio for Pfizer is 6.481 (2025-06-12), with an average CAPE of 8.056. The lowest CAPE Ratio was 3.038 on 2009-03-02, and the highest was 17.299 on 2021-12-16.
Pfizer’s CAPE ratio compares the company’s stock price to its average earnings over the past 10 years, adjusted for inflation. This metric helps investors assess whether Pfizer is overvalued or undervalued relative to its long-term earnings potential. A higher CAPE ratio may indicate the stock is overpriced, while a lower ratio could suggest it’s undervalued. Given Pfizer’s role in the pharmaceutical industry, factors like drug development success and market dynamics heavily influence its CAPE ratio.
CAPE Statistics for Pfizer (2006-07-03 to 2025-06-12)
- Current CAPE: 6.481 (1.47%)
- Min: 3.038 (2009-03-02)
- Max: 17.299 (2021-12-16)
- Mean: 8.056
- Median: 7.716
Pfizer Metrics ( 2015-06-15 to 2025-06-12)
- Current Price: 24.84$ (1.47%)
- YTD Return: -6.65%
- Annualized Volatility YTD: 26.46%
- Average Annual Return: 1.05%
- Compound Annual Growth Rate (CAGR): -2.59%
- Beta (5Y Monthly): 0.57